Virax Biolabs Group Ltd
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jan 9, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $1 | 44% |
| Mar 31, 2025 | HC Wainwright & Co. | initiate | — → Buy | $3 | 44% |
No cross-platform signals in the last 90 days